Flow‐mediated dilatation has no independent prognostic effect in patients with chest pain with or without ischaemic heart disease

Abstract

Objective: The purpose of this study was to assess the prognostic effect of flow‐mediated dilatation (FMD) in patients with chest pain admitted to a coronary care unit. Methods: Endothelium‐dependent FMD in the brachial artery was examined in 223 patients with acute chest pain. All patients underwent a stress test at the time of admittance. On the basis of a positive stress test, a prior myocardial infarction (MI), prior percutaneous coronary intervention (PCI) or coronary bypass surgery (CABG), 137 patients were categorized as having ischaemic heart disease (IHD). Results: Patients with IHD had significantly lower FMD than patients without IHD (p=0.002). During a mean follow‐up of 4.2 years, 90 patients had an endpoint event, i.e. cardiovascular death, acute MI, unstable angina pectoris, PCI or CABG. In univariate analysis, FMD <3 % was associated with an increased hazard of the combined endpoint (p=0.04). In multivariate analysis, adjusted for age, gender, IHD and body mass index, no association between FMD and the combined endpoint was found (p=0.99). Conclusion: FMD is associated with IHD, but has no independent prognostic effect in patients with chest pain.

• Atherosclerosis
• cardiovascular disease
• myocardial infarction
• vascular endothelium
• vasodilatation